Literature DB >> 7743759

Final adult height and its relationship to blood glucose control and microvascular complications in IDDM.

J Penfold1, H P Chase, G Marshall, C F Walravens, P A Walravens, S K Garg.   

Abstract

The effect of longitudinal blood glucose control on final adult height was evaluated in 181 subjects (94 women and 87 men) with IDDM. Diabetes onset was at a median age of 6.9 years with an interquartile range of 4.7 years. Longitudinal glycated haemoglobin values were determined over a mean period of 6.6 +/- 2.6 years during their growth phase. Serial eye and joint examinations and urinary albumin excretion rates were performed with final assessment being carried out at a mean age of 21.1 +/- 3.0 years. The mean adult height standard deviation score of the whole group was -0.22 +/- 1.15 and was reduced compared to the mean height of the general population and to the mean height of the subjects' parents and siblings. There was an inverse correlation with mean longitudinal glycated haemoglobin and final adult height (p < 0.01). There was also an inverse relationship between adult height and the severity of eye, kidney, and joint complications, but when controlled by glycated haemoglobin, this relationship only remained significant for eye complications. Final adult height is reduced in subjects with early onset IDDM who remain in poor blood glucose control during their growth period.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743759     DOI: 10.1111/j.1464-5491.1995.tb00443.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

Review 1.  Growth in patients with type 1 diabetes.

Authors:  Deborah M Mitchell
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-02       Impact factor: 3.243

2.  Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study.

Authors:  R Amin; T K Bahu; B Widmer; R N Dalton; D B Dunger
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

3.  Reduced Bone Mineral Density Is Associated with Celiac Disease Autoimmunity in Children with Type 1 Diabetes.

Authors:  Kimber M Simmons; Kim McFann; Iman Taki; Edwin Liu; Georgeanna J Klingensmith; Marian J Rewers; Brigitte I Frohnert
Journal:  J Pediatr       Date:  2015-11-11       Impact factor: 4.406

Review 4.  Linear Growth in Children and Adolescents with Type 1 Diabetes Mellitus.

Authors:  Elisa Santi; Giorgia Tascini; Giada Toni; Maria Giulia Berioli; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-09-30       Impact factor: 3.390

5.  Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.

Authors:  Johan Wadén; Carol Forsblom; Lena M Thorn; Markku Saraheimo; Milla Rosengård-Bärlund; Outi Heikkilä; Kustaa Hietala; Ken Ong; Nicholas Wareham; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

6.  The Relationship between Metabolic Control and Growth in Children with Type I Diabetes Mellitus in Southwest of Iran.

Authors:  Shide Assar; Koroush Riahi; Shiva Bashirnezhad; Leila Yazdanpanah; Seyed Mahmoud Latifi
Journal:  Scientifica (Cairo)       Date:  2015-09-20

Review 7.  Growth abnormalities in children with type 1 diabetes, juvenile chronic arthritis, and asthma.

Authors:  Cosimo Giannini; Angelika Mohn; Francesco Chiarelli
Journal:  Int J Endocrinol       Date:  2014-02-04       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.